We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Recent Court Victories Embolden FDA to Target Drugmakers' Profits
Recent Court Victories Embolden FDA to Target Drugmakers' Profits
December 9, 2005
The FDA is planning to more aggressively pursue pharmaceutical companies’ profits as a penalty for misbranding or adulteration of medicines — an effort sparked by a string of legal victories upholding the agency’s right to seek such damages.